Endocrine Therapy Drugs (ETDs) Market to Witness Growth Owing to Increasing Incidence of Breast Cancer
Endocrine Therapy Drugs Market |
The endocrine therapy drugs (ETDs) market comprises drugs that are used for the treatment of breast cancer through blocking the production and function of estrogen hormone. Some key ETDs include tamoxifen, aromatase inhibitors such as anastrozole, letrozole, and exemestane. These drugs play a crucial role in managing breast cancer at different stages by either blocking estrogen receptors or lowering estrogen levels in the body.
The Global Endocrine Therapy Drugs (ETDs) Market is estimated to be valued at US$ 35060.96 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the endocrine therapy drugs (ETDs) market include Johnson & Johnson (US), Procter & Gamble (US), Kimberly-Clark (US), Essity Aktiebolag (publ) (Sweden), Kao Corporation (Japan), Daio Paper Corporation (Japan), Unicharm Corporation (Japan), Premier FMCG (South Africa), Ontex (Belgium), Hengan International Group Company Ltd. (China), Drylock Technologies (Belgium), Natracare LLC (US), First Quality Enterprises, Inc. (US), Bingbing Paper Co., Ltd. (China). Key opportunities in the market include expanding production facilities and focused R&D towards developing novel drugs with improved efficacy and reduced side effects. Growing prevalence of breast cancer worldwide has prompted market players to expand their operations across emerging countries.
Market drivers:
One of the key drivers for Endocrine Therapy Drugs Market Growth is the increasing incidence of breast cancer worldwide. As per WHO estimates, breast cancer accounts for nearly 1 in 4 cancer cases among women globally. Growing awareness about early detection and effective management of breast cancer through endocrine therapies is also expected to boost market revenue over the forecast period.
PEST Analysis
Political: The ETDs market is regulated by governmental bodies that approve new drugs and set pricing and reimbursement policies. Changes in healthcare policies impact the demand for ETDs.
Economic: Economic growth influences healthcare expenditures. Recessions can negatively impact sales as patients prioritize other spending over treatment. Also, income levels determine affordability of premium brands.
Social: Aging populations and rising cancer incidence drive the need for ETDs. Growing health awareness increases diagnosis rates and boosts the market. However, social stigma or misinformation around certain illnesses can affect treatment uptake.
Technological: Advancements in drug delivery systems, targeted therapies, and biomarkers support the development of novel ETDs with greater efficacy and fewer side effects. Technologies for large-scale manufacturing help reduce production costs.
The ETDs market sees concentration of value in developed regions including North America, Western Europe, and Japan, largely attributed to the well-established healthcare infrastructure and higher affordability in these markets. However, developing regions in Asia Pacific and Latin America are witnessing faster growth prospects owing to economic expansion, improving access to healthcare, and growing medical needs of expanding middle-class populations. countries like China, India, Brazil and Mexico present high potential for ETDs manufacturers.
The ETDs industry witnesses geographical concentration of value mostly in developed markets of North America, Western Europe, and Japan due to strong healthcare systems and affordability in these regions. However, developing regions in Asia Pacific and Latin America exhibit rapid market growth on account of improving economic conditions, increasing access to healthcare, and augmenting medical requirements of expanding middle-income groups within countries such as China, India, Brazil and Mexico.
Get more insights on Endocrine Therapy Drugs Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment